With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.

This article focuses on the historical developments, present state and future outlook for immunotherapy with haptens as a therapeutic modality for allergic contact dermatitis. Inspired by the ...

Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives itch and is involved in inflammation and skin barrier ...

According to Statifacts, the global allergy diagnostic market size is calculated at USD 6,711 million in 2025 and is expected ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...

A 28-year-old woman developed allergic contact dermatitis within 6 to 24 hours exclusively after using carmine-containing eyeshadows and lipsticks. She had both a positive patch test result and a ...

Researchers don’t fully understand the causes of atopic dermatitis. Both environmental and genetic factors seem to play a role. Many people with atopic dermatitis also have asthma or allergic rhinitis ...

Nektar Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric patients 12 years ...

FOOD allergies (FA) affect millions of children worldwide, causing severe allergic reactions, including anaphylaxis.

More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.

China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of Stapokibart to treat seasonal allergic rhinitis ...